{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:08:40Z","timestamp":1791727720867,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2025.126727","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T10:21:28Z","timestamp":1736850088000},"page":"126727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Active vaccine safety surveillance in low- and middle-income countries: Challenges for vaccine manufacturers from emerging countries"],"prefix":"10.1016","volume":"48","author":[{"given":"Patricia Mouta Nunes","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetanraj","family":"Bhamare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Beatriz Bastos","family":"Lucchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126727_bb0005","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.vaccine.2023.07.041","article-title":"Benefit-risk assessment of vaccines","volume":"42","author":"Kochhar","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126727_bb0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/bcp.15193","article-title":"Pharmacovigilance in low- and middle-income countries: a review with particular focus on Africa","volume":"89","author":"Kiguba","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.vaccine.2025.126727_bb0015","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the vaccine adverse event reporting system (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126727_bb0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/14760584.2014.866895","article-title":"Active surveillance for adverse events following immunization","volume":"13","author":"Crawford","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.126727_bb0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s43441-022-00415-y","article-title":"A systematic review of pharmacovigilance Systems in Developing Countries Using the WHO pharmacovigilance indicators","volume":"56","author":"Garashi","year":"2022","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.vaccine.2025.126727_bb0030","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","article-title":"A global database of COVID-19 vaccinations","volume":"5","author":"Mathieu","year":"2021","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.vaccine.2025.126727_bb0035","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41562-021-01160-2","article-title":"Author correction: a global database of COVID-19 vaccinations","volume":"5","author":"Mathieu","year":"2021","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.vaccine.2025.126727_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-014544","article-title":"Collaboration within the global vaccine safety surveillance ecosystem during the COVID-19 pandemic: lessons learnt and key recommendations from the COVAX vaccine safety working group","volume":"9","author":"Chandler","year":"2024","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2025.126727_bb0045","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126727_bb0050","author":"European Medicines Agency"},{"key":"10.1016\/j.vaccine.2025.126727_bb0055","author":"European Medicines Agency"},{"key":"10.1016\/j.vaccine.2025.126727_bb0060","author":"International Conference on Harmonisation (ICH)"},{"key":"10.1016\/j.vaccine.2025.126727_bb0065","first-page":"11","article-title":"COVID-19 vaccine safety monitoring studies in low- and middle-income countries (LMICs)-a systematic review of study designs and methods","author":"Sisay","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.126727_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071079","article-title":"Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review","volume":"13","author":"Menang","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2025.126727_bb0075","author":"DCVMN"},{"key":"10.1016\/j.vaccine.2025.126727_bb0080","author":"DCVMN"},{"key":"10.1016\/j.vaccine.2025.126727_bb0085","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126727_bb0090","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126727_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100485","article-title":"Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally","volume":"18","author":"ShamaeiZadeh","year":"2024","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2025.126727_bb0100","author":"Council for International Organizations of Medical Sciences (CIOMS)"},{"key":"10.1016\/j.vaccine.2025.126727_bb0105","author":"Council for International Organizations of Medical Sciences (CIOMS)"},{"key":"10.1016\/j.vaccine.2025.126727_bb0110","author":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)"},{"key":"10.1016\/j.vaccine.2025.126727_bb0115","author":"DCVMN"},{"key":"10.1016\/j.vaccine.2025.126727_bb0120","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126727_bb0125","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.126727_bb0130","author":"Vaccines for Europe (vac4eu)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T18:01:50Z","timestamp":1743876110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":26,"alternative-id":["S0264410X25000246"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126727","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active vaccine safety surveillance in low- and middle-income countries: Challenges for vaccine manufacturers from emerging countries","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126727"}}